Population pharmacokinetics of paracetamol across the human age‐range from (pre)term neonates, infants, children to adults
- 30 December 2013
- journal article
- clinical trial
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 54 (6) , 619-629
Abstract
In order to characterize the variation in pharmacokinetics of paracetamol across the human age span, we performed a population pharmacokinetic analysis from preterm neonates to adults with specific focus on clearance. Concentration‐time data obtained in 220 neonates (post‐natal age 1–76 days, gestational age 27–42 weeks), infants (0.11–1.33 yrs), children (2–7 yrs) and adults (19–34 yrs) were analyzed using NONMEM 7.2. In the covariate analysis, linear functions, power functions, and a power function with a bodyweight‐dependent exponent were tested. Between preterm neonates and adults, linear bodyweight functions were identified for Q2, Q3, V1, V2, and V3, while for CL a power function with a bodyweight‐dependent exponent k was identified (CLi = CLp × (BW/70)k). The exponent k was found to decrease in a sigmoidal manner with bodyweight from 1.2 to 0.75, with half the decrease in exponent reached at 12.2 kg. No other covariates such as age were identified. A pharmacokinetic model for paracetamol characterizing changes in pharmacokinetic parameters across the pediatric age‐range was developed. Clearance was found to change in a nonlinear manner with bodyweight. Based on the final model, dosing guidelines are proposed from preterm neonates to adolescents resulting in similar exposure across all age ranges.Keywords
This publication has 32 references indexed in Scilit:
- Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and XposeCPT: Pharmacometrics & Systems Pharmacology, 2013
- Paracetamol to induce ductus arteriosus closure: is it valid?Archives of Disease in Childhood, 2013
- Body Weight-Dependent Pharmacokinetics of Busulfan in Paediatric Haematopoietic Stem Cell Transplantation PatientsClinical Pharmacokinetics, 2012
- A Bodyweight-Dependent Allometric Exponent for Scaling Clearance Across the Human Life-SpanPharmaceutical Research, 2012
- Ductal Closure With Paracetamol: A Surprising New Approach to Patent Ductus Arteriosus TreatmentPediatrics, 2011
- Systematic Evaluation of the Descriptive and Predictive Performance of Paediatric Morphine Population ModelsPharmaceutical Research, 2010
- Pharmacokinetics and analgesic effects of intravenous propacetamol vs rectal paracetamol in children after major craniofacial surgeryPediatric Anesthesia, 2008
- Metrics for External Model Evaluation with an Application to the Population Pharmacokinetics of GliclazidePharmaceutical Research, 2006
- Building population pharmacokineticpharmacodynamic models. I. Models for covariate effectsJournal of Pharmacokinetics and Biopharmaceutics, 1992
- Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous useFundamental & Clinical Pharmacology, 1992